Back to Rankings

QTTB

Q32 BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
QTTB vs peer average
49/100
QTTB vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · C 1 · D 3 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

INMB is the first available peer comparator.

Clinical-stage biotech with similar small-cap volatility and dependence on future data; again a loose risk-profile peer rather than a direct alopecia/immunology comp.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerINMBINmune Bio
QTTB
Q32 Bio
INMB
INmune Bio
Grade
D
F
Momentum
97
16
Value
41
41
Sentiment
0
-
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs INMB

QTTB / INMB
Grade Position
In line
QTTB vs. peer average (D vs. D)
49/100
Momentum
97
QTTB
Value
41
QTTB
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs QTTB
1
INMB
INMB
F
20/100
+1
2
BTAI
BTAI
F
20/100
+1
3
IBIO
IBIO
B
80/100
-2
4
CGEN
Compugen Ltd Common
A
100/100
-3
5
FHTX
Foghorn Therapeutics Inc Common
C
60/100
-1
INMB is the first peer returned for this comparison set.